adenine has been researched along with Peripheral Nerve Injury in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ko, PY | 1 |
| Yang, CC | 1 |
| Kuo, YL | 1 |
| Su, FC | 1 |
| Hsu, TI | 1 |
| Tu, YK | 1 |
| Jou, IM | 1 |
| Wang, B | 1 |
| Ning, H | 1 |
| Reed-Maldonado, AB | 1 |
| Zhou, J | 1 |
| Ruan, Y | 1 |
| Zhou, T | 1 |
| Wang, HS | 1 |
| Oh, BS | 1 |
| Banie, L | 1 |
| Lin, G | 1 |
| Lue, TF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy and Safety of Transcranial Pulse Stimulation (TPS) in Older Adults With Mild Neurocognitive Disorder - an Open-label Self-controlled Trial[NCT05331560] | 20 participants (Anticipated) | Interventional | 2020-01-20 | Recruiting | |||
| Efficacy of a 24-week Long Term Transcranial Pulse Stimulation (TPS) on Cognition and Brain Structure in Older Adults With Mild Neurocognitive Disorder (NCD)[NCT05602467] | 22 participants (Anticipated) | Interventional | 2022-11-25 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for adenine and Peripheral Nerve Injury
| Article | Year |
|---|---|
Schwann-Cell Autophagy, Functional Recovery, and Scar Reduction After Peripheral Nerve Repair.
Topics: Adenine; Animals; Autophagy; Cicatrix; Male; Nerve Regeneration; Peripheral Nerve Injuries; Rats; Ra | 2018 |
Low-Intensity Extracorporeal Shock Wave Therapy Enhances Brain-Derived Neurotrophic Factor Expression through PERK/ATF4 Signaling Pathway.
Topics: Activating Transcription Factor 4; Adenine; Animals; Brain-Derived Neurotrophic Factor; Disease Mode | 2017 |
Low-Intensity Extracorporeal Shock Wave Therapy Enhances Brain-Derived Neurotrophic Factor Expression through PERK/ATF4 Signaling Pathway.
Topics: Activating Transcription Factor 4; Adenine; Animals; Brain-Derived Neurotrophic Factor; Disease Mode | 2017 |
Low-Intensity Extracorporeal Shock Wave Therapy Enhances Brain-Derived Neurotrophic Factor Expression through PERK/ATF4 Signaling Pathway.
Topics: Activating Transcription Factor 4; Adenine; Animals; Brain-Derived Neurotrophic Factor; Disease Mode | 2017 |
Low-Intensity Extracorporeal Shock Wave Therapy Enhances Brain-Derived Neurotrophic Factor Expression through PERK/ATF4 Signaling Pathway.
Topics: Activating Transcription Factor 4; Adenine; Animals; Brain-Derived Neurotrophic Factor; Disease Mode | 2017 |